A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
Clinical trial NCT04883593 · COMPLETED
Trial details
- NCT number
- NCT04883593
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2021-02-20
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.